coin-img-BTCBTC-0.77%coin-img-SOLSOL-0.83%coin-img-USDCUSDC+0.02%coin-img-XRPXRP-1.34%coin-img-HYPEHYPE+3.26%coin-img-TRXTRX+0.30%coin-img-ADAADA-0.10%coin-img-ETHETH-1.07%coin-img-BTCBTC-0.77%coin-img-SOLSOL-0.83%coin-img-USDCUSDC+0.02%coin-img-XRPXRP-1.34%coin-img-HYPEHYPE+3.26%coin-img-TRXTRX+0.30%coin-img-ADAADA-0.10%coin-img-ETHETH-1.07%coin-img-BTCBTC-0.77%coin-img-SOLSOL-0.83%coin-img-USDCUSDC+0.02%coin-img-XRPXRP-1.34%coin-img-HYPEHYPE+3.26%coin-img-TRXTRX+0.30%coin-img-ADAADA-0.10%coin-img-ETHETH-1.07%coin-img-BTCBTC-0.77%coin-img-SOLSOL-0.83%coin-img-USDCUSDC+0.02%coin-img-XRPXRP-1.34%coin-img-HYPEHYPE+3.26%coin-img-TRXTRX+0.30%coin-img-ADAADA-0.10%coin-img-ETHETH-1.07%
user-avatar
CNBC TV18

Blue Jet Healthcare shares slide 5% on August 3 after Q1 profit and revenue fall year-on-year

AI Market Summary
Blue Jet Healthcare reported weaker FY2024 Q1 results, with revenue down 17.4% YoY, net profit down 14.2%, and EBITDA down 19% alongside margin compression to 33.4%. The stock fell as much as 5% intraday as investors repriced near-term earnings quality. Market impact is largely idiosyncratic, with limited read-through beyond Indian pharma risk sentiment.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-0.12%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▼ Bearish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Blue Jet Healthcare reported fiscal 2024 first-quarter results for the quarter ended June, with revenue down 17.4% year-on-year to ₹293 crore. Net profit fell 14.2% to ₹78 crore, while EBITDA declined 19% to ₹98 crore and the EBITDA margin narrowed to 33.4%. The stock fell as much as 5% intraday on August 3 as investors reacted to the weaker year-on-year performance.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.